TARS - Tarsus Pharmaceuticals GAAP EPS of -$1.01 beats by $0.18 revenue of $27.61M beats by $9.71M
2024-05-08 17:08:37 ET
More on Tarsus Pharmaceuticals
- Tarsus Pharmaceuticals: A Strong Launch For An Under The Radar Name
- Tarsus Pharmaceuticals, Inc. (TARS) Q4 2023 Earnings Call Transcript
- Tarsus Pharmaceuticals Q1 2024 Earnings Preview
- Tarsus refinances existing debt with $200M financing commitment
- Seeking Alpha’s Quant Rating on Tarsus Pharmaceuticals